2 terminated, 1 suspended. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Suspended 1 |
Follow cangrelor: new trials by email Literature Review of cangrelor trials Research Report on cangrelor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts Cangrelor, best medical management - Acute Ischemia | Phase 3 | Suspended | Fondation Ophtalmologique Adolphe de Rothschild | 368 | 2022-03-02 | 2026-09-25 |
| Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. Cangrelor, clopidogrel, Placebo bolus & placebo infusion - Atherosclerosis, Acute Coronary Syndrome (ACS) | Phase 3 | Terminated | The Medicines Company | 5364 | 2006-09-01 | 2014-05-05 |
| A Clinical Trial to Demonstrate the Efficacy of Cangrelor Cangrelor (P2Y12 inhibitor), clopidogrel (oral P2Y12 inhibitor), Placebo bolus & placebo infusion - Myocardial Infarction (MI), Acute Coronary Syndromes (ACS) | Phase 3 | Terminated | The Medicines Company | 8882 | 2006-04-01 | 2014-05-08 |
Acute Coronary Syndrome (2) · Atherosclerosis (1) · Myocardial Infarction (1) · Non-ST Elevated Myocardial Infarction (1) · ST Elevation Myocardial Infarction (1)
The Medicines Company (2) · Fondation Ophtalmologique Adolphe de Rothschild (1)
United States (2) · France (1)
Deepak L. Bhatt, MD (2) · Robert A. Harrington, MD (2) · Simona Skerjanec, PharmD (2)
PMID 22305835, PMID 27902833, PMID 28382371, PMID 28988157, PMID 29632238, PMID 35196863, PMID 38551015, PMID 19915221, PMID 19915222